Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1998 | 1 |
2007 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Clinical and genetic spectrum of a large cohort of patients with δ-sarcoglycan muscular dystrophy.
Brain. 2022 Apr 18;145(2):596-606. doi: 10.1093/brain/awab301.
Brain. 2022.
PMID: 34515763
Free PMC article.
Our aim was to characterize the clinical and genetic spectrum of a large international cohort of LGMDR6 patients and to investigate whether or not genetic or protein expression data could predict a disease's severity. This is a retrospective study collecting demographic, g …
Our aim was to characterize the clinical and genetic spectrum of a large international cohort of LGMDR6 patients and to investigate whether …
A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle muscular dystrophy type 2F (LGMD2F) in Brazilian sarcoglycanopathies.
Moreira ES, Vainzof M, Marie SK, Nigro V, Zatz M, Passos-Bueno MR.
Moreira ES, et al.
J Med Genet. 1998 Nov;35(11):951-3. doi: 10.1136/jmg.35.11.951.
J Med Genet. 1998.
PMID: 9832045
Free PMC article.
Interestingly, this new mutation is also associated with a severe clinical course. In addition, our results suggest that this form of severe AR LGMD is not very rare in our population....
Interestingly, this new mutation is also associated with a severe clinical course. In addition, our results suggest that this form of …
Item in Clipboard
A new evidence for the maintenance of the sarcoglycan complex in muscle sarcolemma in spite of the primary absence of delta-SG protein.
Gouveia TL, Kossugue PM, Paim JF, Zatz M, Anderson LV, Nigro V, Vainzof M.
Gouveia TL, et al.
J Mol Med (Berl). 2007 Apr;85(4):415-20. doi: 10.1007/s00109-007-0163-8. Epub 2007 Jan 30.
J Mol Med (Berl). 2007.
PMID: 17265058
The patient started clinical manifestation at age 25, with frequent falls, but he is currently able to walk unassisted at age 42. His clinical course is significantly milder when compared to several other affected patients carrying the same mutation associated with a total …
The patient started clinical manifestation at age 25, with frequent falls, but he is currently able to walk unassisted at age 42. His clinic …
Item in Clipboard
Cite
Cite